Young and emerging biotechnology companies rarely have enough background in biomanufacturing operations and clinical experience to get their products to the markets in an economic and efficient manner ...
The term “sustainability” usually brings to mind consumer products—not life-saving biologics such as recombinant proteins, monoclonal antibodies, and vaccines. Somehow, with biologics, we overlook the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback